• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者支气管肺泡灌洗液中通过下一代测序鉴定的真菌:一项回顾性研究。

Fungi identified via next-generation sequencing in bronchoalveolar lavage fluid among patients with COVID-19: a retrospective study.

机构信息

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Eur J Med Res. 2024 Sep 17;29(1):463. doi: 10.1186/s40001-024-02054-5.

DOI:10.1186/s40001-024-02054-5
PMID:39289769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11406842/
Abstract

BACKGROUND

The epidemiology of fungi identified via next-generation sequencing in bronchoalveolar lavage fluid among patients with COVID-19 is unknown.

METHODS

De-identified information, including age, SARS-CoV-2 reads and fungi from bronchoalveolar lavage fluid, were used to analysis.

RESULTS

A total of 960 patients with COVID-19 were included. Gender was unknown in 38 patients, and 648 (70.3%) of the rest patients were male. For 876 patients with information on age, their mean ± standard age was 63.4 ± 21.3 years, with the minimum being 0.2 years and the maximum being 101 years. For all the patients, their median [interquartile range] SARS-CoV-2 reads were 26,038 [4421.5, 44,641.5]. The Aspergilli were identified in 159 (16.6%) patients, with Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger in 103 (10.7%), 81 (8.4%) and 17 (1.8%), respectively. The Mucoraceae were identified in 14 (1.5%) patients. Pneumocystis jirovecii was identified in 65 (6.8%) patients, among whom 12 (18.5%) patients also had Aspergilli. The Cryptococcaceae and the Dematiaceae were also identified in some patients, including Cryptococcus in 11 (1.1%) patients.

CONCLUSIONS

In bronchoalveolar lavage fluid among patients with COVID-19, the Aspergilli were very commonly identified, as were the Mucoraceae, Pneumocystis jirovecii and Cryptococcus via next-generation sequencing.

摘要

背景

COVID-19 患者支气管肺泡灌洗液中通过下一代测序鉴定的真菌的流行病学尚不清楚。

方法

使用鉴定信息,包括年龄、SARS-CoV-2 读取和支气管肺泡灌洗液中的真菌进行分析。

结果

共纳入 960 例 COVID-19 患者。38 例患者性别不详,其余 648 例(70.3%)为男性。对于 876 例有年龄信息的患者,其平均年龄为 63.4 ± 21.3 岁,年龄最小为 0.2 岁,最大为 101 岁。对于所有患者,其中位数[四分位数范围]SARS-CoV-2 读数为 26038[4421.5, 44641.5]。159 例(16.6%)患者中鉴定出曲霉菌,103 例(10.7%)、81 例(8.4%)和 17 例(1.8%)分别为烟曲霉、黄曲霉和黑曲霉。14 例(1.5%)患者中鉴定出毛霉科。65 例(6.8%)患者中鉴定出卡氏肺孢子菌,其中 12 例(18.5%)患者也有曲霉菌。一些患者中还鉴定出隐球菌科和暗色孢科,包括 11 例(1.1%)患者的隐球菌。

结论

在 COVID-19 患者的支气管肺泡灌洗液中,通过下一代测序非常常见地鉴定出曲霉菌、毛霉科、卡氏肺孢子菌和隐球菌。

相似文献

1
Fungi identified via next-generation sequencing in bronchoalveolar lavage fluid among patients with COVID-19: a retrospective study.COVID-19 患者支气管肺泡灌洗液中通过下一代测序鉴定的真菌:一项回顾性研究。
Eur J Med Res. 2024 Sep 17;29(1):463. doi: 10.1186/s40001-024-02054-5.
2
The bacterial and fungal profiles of patients hospitalized with non-COVID-19 lower respiratory tract infections in Wuhan, China, 2019-2021.中国武汉 2019-2021 年因非 COVID-19 下呼吸道感染住院的患者的细菌和真菌谱。
J Appl Microbiol. 2024 Jul 2;135(7). doi: 10.1093/jambio/lxae150.
3
Next-generation sequencing technology for detecting pulmonary fungal infection in bronchoalveolar lavage fluid of a patient with dermatomyositis: a case report and literature review.应用下一代测序技术检测皮肌炎患者支气管肺泡灌洗液中的肺部真菌感染:病例报告及文献复习。
BMC Infect Dis. 2020 Aug 17;20(1):608. doi: 10.1186/s12879-020-05341-8.
4
Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study.支气管肺泡灌洗液宏基因组下一代测序用于鉴定肺部感染患者的病原体:一项回顾性研究。
Diagn Microbiol Infect Dis. 2024 Sep;110(1):116402. doi: 10.1016/j.diagmicrobio.2024.116402. Epub 2024 Jun 12.
5
Pulmonary microbial spectrum in late-stage SARS-CoV-2 infection: a case series.晚期 SARS-CoV-2 感染的肺部微生物谱:病例系列。
Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2037-2046. doi: 10.1007/s10096-024-04897-6. Epub 2024 Jul 20.
6
Application of Diagnostic Stewardship to Fungal Polymerase Chain Reaction: Low Yield of Follow-up Testing on Plasma and Bronchoalveolar Lavage After a Negative Result.诊断管理在真菌聚合酶链反应中的应用:阴性结果后对血浆和支气管肺泡灌洗液进行后续检测的产量低。
Clin Infect Dis. 2024 Oct 15;79(4):944-952. doi: 10.1093/cid/ciae382.
7
Metagenomic versus targeted next-generation sequencing for detection of microorganisms in bronchoalveolar lavage fluid among renal transplantation recipients.宏基因组与靶向二代测序在肾移植受者支气管肺泡灌洗液中检测微生物中的应用比较。
Front Immunol. 2024 Aug 26;15:1443057. doi: 10.3389/fimmu.2024.1443057. eCollection 2024.
8
Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.宏基因组下一代测序在免疫功能低下患者疑似肺炎诊断中的应用
BMC Infect Dis. 2022 Apr 29;22(1):416. doi: 10.1186/s12879-022-07381-8.
9
Metagenomic next-generation sequencing targeted and metagenomic next-generation sequencing for pulmonary infection in HIV-infected and non-HIV-infected individuals.宏基因组下一代测序靶向检测与宏基因组下一代测序在 HIV 感染和非 HIV 感染个体肺部感染中的应用。
Front Cell Infect Microbiol. 2024 Aug 19;14:1438982. doi: 10.3389/fcimb.2024.1438982. eCollection 2024.
10
Development and Evaluation of a Fully Automated Molecular Assay Targeting the Mitochondrial Small Subunit rRNA Gene for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid Specimens.开发并评估一种针对线粒体小亚基 rRNA 基因的全自动分子检测方法,用于检测支气管肺泡灌洗液标本中的肺孢子菌。
J Mol Diagn. 2020 Dec;22(12):1482-1493. doi: 10.1016/j.jmoldx.2020.10.003. Epub 2020 Oct 15.

本文引用的文献

1
Evaluation of metagenomic next-generation sequencing diagnosis for invasive pulmonary aspergillosis in immunocompromised and immunocompetent patients.评估宏基因组下一代测序诊断免疫抑制和免疫功能正常患者侵袭性肺曲霉病的价值。
Mycoses. 2023 Apr;66(4):331-337. doi: 10.1111/myc.13557. Epub 2023 Jan 11.
2
Inconsistency analysis between metagenomic next-generation sequencing results of cerebrospinal fluid and clinical diagnosis with suspected central nervous system infection.脑脊液宏基因组下一代测序结果与疑似中枢神经系统感染的临床诊断之间的不一致性分析。
BMC Infect Dis. 2022 Sep 30;22(1):764. doi: 10.1186/s12879-022-07729-0.
3
COVID-19-associated fungal infections.COVID-19 相关真菌感染。
Nat Microbiol. 2022 Aug;7(8):1127-1140. doi: 10.1038/s41564-022-01172-2. Epub 2022 Aug 2.
4
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.COVID-19 相关毛霉病的出现:来自 18 个国家的病例回顾。
Lancet Microbe. 2022 Jul;3(7):e543-e552. doi: 10.1016/S2666-5247(21)00237-8. Epub 2022 Jan 25.
5
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients.新冠病毒感染患者中除侵袭性曲霉病之外的真菌感染
J Fungi (Basel). 2022 Jan 6;8(1):58. doi: 10.3390/jof8010058.
6
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.COVID-19 机械通气患者真菌感染:法国多中心 MYCOVID 研究。
Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26.
7
Invasive Fungal Infections Complicating COVID-19: A Narrative Review.新型冠状病毒肺炎合并侵袭性真菌感染:一篇叙述性综述
J Fungi (Basel). 2021 Oct 29;7(11):921. doi: 10.3390/jof7110921.
8
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.COVID-19 相关的肺曲霉病、菌血症和肺囊虫病在重症监护病房:法国第一波大流行期间的回顾性多中心观察队列研究。
Microbiol Spectr. 2021 Oct 31;9(2):e0113821. doi: 10.1128/Spectrum.01138-21. Epub 2021 Oct 20.
9
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU.包含真菌生物标志物的新临床算法,以更好地诊断重症监护病房中可能的侵袭性肺曲霉病。
Ann Intensive Care. 2021 Mar 8;11(1):41. doi: 10.1186/s13613-021-00827-3.
10
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病:2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.